Abstracting and Indexing

  • CrossRef
  • WorldCat
  • Google Scholar
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE

Three Critical COVID-19 Cases Treated with Mesenchymal Stem Cells: A Case Series Report

Author(s): Karakoc ZC, Koyuncu Irmak D, Tugrul S, Ece F, Gormeli CA, Ozyilmaz K, Karaoz E

This paper reports three critically ill patients diagnosed COVID-19 infection who were treated with conventional therapy and MSCs add-on therapy in combined treatment protocols on a patient centric manner. We followed up and evaluated the cases specifically for efficacy and safety indicators. We introduce promising efficacy and safety data of the add on MSC therapy in COVID-19. We believe that the MSC therapy could be a safe effective therapy method for novel coronavirus as add-on therapy and when applied to the critically ill COVID-19 cases on a personalized approach.

Journal Statistics

Impact Factor: * 3.1

CiteScore: 2.9

Acceptance Rate: 11.01%

Time to first decision: 10.4 days

Time from article received to acceptance: 2-3 weeks

Discover More: Recent Articles

Grant Support Articles

    Editor In Chief

    Yasuo Iwasaki

  • Division of Neurology, Department of Internal Medicine
    Toho University School of Medicine
    Ota-ku, Tokyo, Japan

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved!